Daratumumab for the treatment of relapsed/refractory AL amyloidosis : experience from the amyloidosis Program of Calgary (APC)
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 65(2024), 3 vom: 15. Feb., Seite 403-406 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Levin, Daniel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.02.2024 Date Revised 15.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2023.2290468 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM365457418 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM365457418 | ||
| 003 | DE-627 | ||
| 005 | 20240215231942.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2023.2290468 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1294.xml |
| 035 | |a (DE-627)NLM365457418 | ||
| 035 | |a (NLM)38054823 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Levin, Daniel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Daratumumab for the treatment of relapsed/refractory AL amyloidosis |b experience from the amyloidosis Program of Calgary (APC) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.02.2024 | ||
| 500 | |a Date Revised 15.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a daratumumab |2 NLM | |
| 650 | 7 | |a 4Z63YK6E0E |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 700 | 1 | |a Lewis, Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a McCulloch, Sylvia |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Holly |e verfasserin |4 aut | |
| 700 | 1 | |a Tay, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Duggan, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Neri, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Bahlis, Nizar |e verfasserin |4 aut | |
| 700 | 1 | |a Jimenez-Zepeda, Victor H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 65(2024), 3 vom: 15. Feb., Seite 403-406 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:65 |g year:2024 |g number:3 |g day:15 |g month:02 |g pages:403-406 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2023.2290468 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 65 |j 2024 |e 3 |b 15 |c 02 |h 403-406 | ||